Corrigendum to “Kallistatin attenuates inflammatory response in rheumatoid arthritis via the NF-κB signaling pathway” [Eur. J. Pharmacol. 943 (2023) 175530]

European Journal of Pharmacology 2026

View at publisher

Authors: Xiao Wang, Xiaoping Huang, Pingzhang Gao, Yanxuan Ren, Xiaokun Li, Yong Diao

DOI: 10.1016/j.ejphar.2026.178711

Cited by: 0

Fields of Study & Subjects

Natural Compounds in Disease Treatment Rheumatoid Arthritis Research and Therapies NF-κB Signaling Pathways